A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation.

The Kaplan–Meier survival analysis showed a highly significant difference in OS was detected between the high- and low-risk groups (Log-rank test P < 0.0001), suggesting that the expression of these 5 genes can be effectively distinguished the high- and low-risk of these PC patients (Fig. 4 B and Fig. 5 ).

also in 132,142 other papers